[1]杨云,乔宠*.辅助生殖技术中自然流产的处理[J].中国计划生育和妇产科,2017,(1):12-15.
点击复制

辅助生殖技术中自然流产的处理
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2017年1期
页码:
12-15
栏目:
综述
出版日期:
2017-01-25

文章信息/Info

作者:
杨云乔宠*
中国医科大学附属盛京医院妇产科
关键词:
辅助生殖技术自然流产处理
摘要:
辅助生殖技术被广泛应用于不孕症患者中,妊娠成功率已明显提高,但分娩率却很低,其与自然流产有着密切关系。因此为提高辅助生殖技术中产妇的妊娠成功率及胎儿存活率,对自然流产的治疗显得尤为重要。本文对辅助生殖技术中自然流产处理的研究进展进行综述。

参考文献/References:

[1]谢幸,苟文丽妇产科学 [M].第8版.北京:人民卫生出版社,2013:372. [2]陈士岭.辅助生殖技术与自然流产 [J]. 实用妇产科杂志,2016,32(2):87-89. [3]Talaulikar Sinai, Arulkumaran Sabaratnam. Maternal, perinatal and long-term outcomes after assisted reproductive techniques (ART): implications for clinical practice [J]. Eur J Obstet Gynecol Reprod Biol, 2013, 170(1): 13-19. [4]Talaulikar Sinai, Arulkumaran Sabaratnam. Reproductive outcomes after assisted conception [J]. Obstet Gynecol Surv, 2012, 67(9): 566-583. [5]Jackson S, Hong C, Wang ET, et al. Pregnancy outcomes in very advanced maternal age pregnancies: the impact of assisted reproductive technology [J]. Fertil Steril, 2015, 103(1): 76-80. [6]陈文俊,李慧芳,周蓓蓓,等. 卵巢储备功能低下评估及治疗方法研究进展 [J]. 实用医学杂志,2016,32(1):19-22. [7]王琳,连方.高龄妇女与辅助生殖技术 [J]. 中国现代药物应用,2008,2(10):105-106. [8]Practice Committee of the American Society for Reproductive Medicine. Use of clomiphene citrate in infertile women: a committee opinion [J]. Fertil Steril, 2013, 100(2): 341-348. [9]Hajishafiha Masomeh, Dehghan Meisam, Kiarang Nazila, et al. Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome [J]. Drug Des Devel Ther, 2013, 7(4): 1427-1431. [10]Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function [J]. J Assist Reprod Genet, 2007, 24(12): 629-634. [11]Gleicher Norbert, Ryan Eddy, Weghofer Andrea, et al. Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study [J]. Reprod Biol Endocrinol, 2009, 7(4): 108. [12]甄秀梅,乔杰.肥胖患者辅助生殖技术治疗 [J]. 实用妇产科杂志,2011,27(5):329-330. [13]高星,杜惠兰. 辅助生殖技术中子宫内膜容受性治疗的研究进展 [J]. 中华中医药杂志,2016,30 (2):591-594. [14]Achache Hanna, Revel Ariel. Endometrial receptivity markers, the journey to successful embryo implantation [J]. Hum Reprod Update, 2006, 12(6): 731-746. [15]Mcwilliams GD, Frattarelli JL. Changes in measured endometrial thickness predict in vitro fertilization success [J]. Fertil Steril, 2007, 88(1): 74-81. [16]XIANG Y, TAN L. Effect of GH on endometrial receptivity in implantation endometrium of mouse [J]. Journal of Medical Forum, 2006, 27(24): 35-37. [17]覃桂荣,熊艳敏,李柳铭宫腔镜子宫内膜微创术对子宫内膜容受性影响的研究 [J]实用妇科杂志,2014,30(2):128-131 [18]Silverberg M, Vaughn C, Hansard J, et al. Vaginal (crinone 8%) gel vs. intramuscular progesterone in oil for luteal phase support in in vitro fertilization: a large prospective trial [J]. Fertil Steril, 2012, 97(2): 344-348. [19]Ata B, Yakin K, Balaban B, et al. GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study [J]. Hum Reprod, 2008, 23(3): 668-673. [20]Bartmann Karina, Romo Salata, Ramos da, et al. Why do older women have poor implantation rates? A possible role of the mitochondria [J]. J Assist Reprod Genet, 2004, 21(3): 79-83. [21]Gleicher Norbert, Weghofer Andrea, Barad H. Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS)[J]. Reprod Biol Endocrinol, 2010, 8(1): 1-5. [22]郭艺红,孙莹璞.辅助生殖技术相关血栓性疾病的防治 [J]. 生殖与避孕,2014,34(8):664-667. [23]谢幸,苟文丽.妇产科学 [M].第8版.北京:人民卫生出版社,2013:359. [24]González Frank, Kirwan P, Rote S, et al. Elevated circulating levels of tissue factor in polycystic ovary syndrome [J]. Clin Appl Thromb Hemost, 2012, 19(1): 66-72. [25]魏丽坤,张雷,王蔼明子宫内膜容受性的评价及其改善措施 [J]生殖与避孕,2008,28(5):298-303 [26]巴林林亚临床甲状腺功能减退对辅助生殖的影响 [J]实用妇产科杂志,2013,29 (9):656-659 [27]Baker L, Rone M, Pasta J, et al. Correlation of thyroid stimulating hormone (TSH) level with pregnancy outcome in women undergoing in vitro fertilization [J]. Am J Obstet Gynecol, 2006, 194(6):1674-1675. [28]颜耀华,马彩虹,李美芝,等. 高催乳素血症患者体外受精-胚胎移植妊娠结局的临床分析[J]. 中国妇产科临床杂志,2009,10 (6):419-422. [29]Tobias K, Chavarro E, Williams A, et al. History of infertility and risk of gestational diabetes mellitus: a prospective analysis of 40,773 pregnancies[J]. Am J Epidemiol, 2013, 178(8): 1219-1225. [30]Lédée-Bataille N, Koeppel B, Frydman R, et al. The impact of stress in the maternofetal relationship: an immunological approach[J]. Gynecol Obstet Fertil, 2003, 31(9): 778-781.

相似文献/References:

[1]谭欣,朱明辉,贺贞,等.胚胎移植后14~16日血清β-HCG值与早期妊娠结局的关系[J].中国计划生育和妇产科,2010,(02):0.
 TAN Xin,ZHU Ming-hui,HE Zhen,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(1):0.
[2]侯兴华,臧玉芹,张艳,等.甲胎蛋白及增殖细胞核抗原在自然流产中的表达及意义[J].中国计划生育和妇产科,2010,(03):0.
 HOU Xing-hua,ZANG Yu-qin,ZHANG Yan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(1):0.
[3]孙燕萍,张海英.辅助生殖技术应用的伦理学思考[J].中国计划生育和妇产科,2010,(04):0.
[4]朱依敏,张丹,黄荷凤,等.医源性多胎的危害及防控[J].中国计划生育和妇产科,2012,(02):0.
 ZHU Yi-min,ZHANG Dan,HUANG He-feng.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(1):0.
[5]王亚平,郁琦.多囊卵巢综合征的辅助生育治疗[J].中国计划生育和妇产科,2014,(06):0.
[6]杜娟,田东梅,熊洪平,等.控制性超促排卵中垂体激素与卵巢激素的变化分析[J].中国计划生育和妇产科,2014,(07):0.
 DU Juan,TIAN Dong-mei,XIONG Hong-ping,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(1):0.
[7]孙瑜,朱依敏.高龄不育夫妇,现代辅助生殖技术之惑[J].中国计划生育和妇产科,2014,(08):0.
[8]崔淑娟,马艳芬.妊娠期心理压力与自然流产的关系[J].中国计划生育和妇产科,2015,(03):0.
 CUI Shu-juan,MA Yan-fen,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(1):0.
[9]王甲甲,王智斌,黄文芳,等.TORCH病原体感染与自然流产的关系及影响因素[J].中国计划生育和妇产科,2015,(07):0.
 WANG Jia-jia,WANG Zhi-bin,HUANG Wen-fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(1):0.
[10]柴健,蒋丽芳,张军喜,等.河南省农村地区769名妇女的孕前自我健康评价和自然流产的发生[J].中国计划生育和妇产科,2015,(12):0.
 CHAI Jian,JIANG Li-fang,ZHANG Jun-xi,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(1):0.

更新日期/Last Update: 2017-01-25